R
Richard E. Moore
Researcher at University of Hawaii at Manoa
Publications - 284
Citations - 17167
Richard E. Moore is an academic researcher from University of Hawaii at Manoa. The author has contributed to research in topics: Lyngbya majuscula & Debromoaplysiatoxin. The author has an hindex of 70, co-authored 282 publications receiving 16401 citations. Previous affiliations of Richard E. Moore include Meijo University & University of Hawaii.
Papers
More filters
Journal ArticleDOI
Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases.
TL;DR: Microcystin-LR inhibited the activity of both type 1 and type 2A phosphatases greater than 10-fold more potently than okadaic acid under the same conditions and may prove to be a useful probe for the study and identification cellular processes which are mediated by protein phosphatase.
Journal ArticleDOI
Cylindrospermopsin: a potent hepatotoxin from the blue-green alga Cylindrospermopsis raciborskii
Journal ArticleDOI
Palytoxin: a new marine toxin from a coelenterate.
Richard E. Moore,Paul J. Scheuer +1 more
TL;DR: Palytoxin has been isolated from the zoanthids "limu-make-o-Hana" (Tentatively identified as Palythoa sp.) as a noncrystalline, chromatographically pure entity and is the most highly toxic substance known.
Journal ArticleDOI
Naming of cyclic heptapeptide toxins of cyanobacteria (blue-green-algae)
Wayne W. Carmichael,Val R. Beasley,David L. Bunner,Jacobus Nicolaas Eloff,Ian R. Falconer,Paul R. Gorham,Ken-ichi Harada,Thaiya Krishnamurthy,Yu Min-Juan,Richard E. Moore,Kenneth L. Rinehart,Maria T. C. Runnegar,Olav M. Skulberg,Mariyo F. Watanabe +13 more
TL;DR: All photographs courtesy of AFP, EPA, Getty Images and Reuters.
Journal ArticleDOI
Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.
TL;DR: Apratoxin A (1), a potent cytotoxin with a novel skeleton, has been isolated from the marine cyanobacterium Lyngbya majuscula Harvey ex Gomont; however, it was only marginally active in vivo against a colon tumor and ineffective against a mammary tumor.